ORMP - Oramed Pharmaceuticals Inc. Quarterly EPS earnings growth
The licensing potential of capsule insulin for Oramed Pharmaceuticals (ORMP) is countered by fierce competition within the endocrinology sector. Quarterly EPS dynamics help balance these factors, where the value of -62.50 reflects the most recent profit figure. Significant cash reserves and successful medical investments currently provide stability, offsetting previous development risks.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_ORMP_-_Oramed-Pharmaceuticals_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Oramed Pharmaceuticals Inc. (ORMP): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/14/2026 | 👁️GURU.Markets👁️")
Oramed Pharmaceuticals (ORMP) - metric breakdowns and financial figures
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Debt to Equity Oramed Pharmaceuticals|ORMP - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital oramed.com|ORMP - Company Aggregate Debts|Debt to Book Capitalization Ratio Oramed Pharma|ORMP - Company Long-Term Liabilities|Company Short-Term Debts Oramed Pharmaceuticals|Quick Ratio oramed.com
- earnings and market multiples details:
ORMP - Company Profit|Future Profit Oramed Pharmaceuticals|ORMP - Company Value to Net Income|Future Price to Earnings oramed.com|ORMP - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Oramed Pharma|ORMP - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Oramed Pharmaceuticals|ORMP - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months oramed.com|ORMP - Earnings per share increase in current year|Net earnings per share growth forecast for next year Oramed Pharmaceuticals
- sales revenue and business income indicators:
Initial company analysis:Oramed Pharmaceuticals
The assessment of Oramed Pharmaceuticals (ORMP) margin of safety is based on an analysis of net earnings per share dynamics, which measures capitalization efficiency and asset protection against inflation. By tracking the quarterly EPS growth rate, an investor can verify management's discipline in managing the cash cushion and controlling capital expenditures while seeking new biotechnological assets.
Main competitors
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Alvotech S.A. (ALVO) - Earnings per share growth in annualized terms for the last twelve months|LQDA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months GLPG (Galapagos Corp)|ANIP: Quarterly EPS earnings growth|mannkindcorp.com (MNKD) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Amphastar Pharmaceuticals, Inc.|Year-over-year net earnings per share growth for the last 12 months Pacira Pharmaceuticals (PCRX)|Quarterly EPS earnings growth SPRY|TBPH - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth AQST (Aquestive Therapeutics)|SCPH: Year-over-year earnings per share growth for the last 12 months|TECX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months TNXP (Tonix Pharma)|sxtchina.com (SXTC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months EPRX (Eupraxia Pharmaceuticals Inc.)|BHST (BioHarvest Sciences) - Quarterly EPS earnings growth|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ENTX|Quarterly EPS earnings growth MindWalk Holdings, Inc. (HYFT)|Year-over-year earnings per share growth for the last twelve months ABVC BioPharma Inc ABVC|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|fibrogen.com (FGEN) - Year-over-year net earnings per share growth for the last 12 months|TELO: Quarterly EPS earnings growth|Rani Therapeutics Holdings, Inc. (RANI) - Quarterly EPS earnings growth|SNYR (Synergy CHC Corp.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Rallybio Corp. (RLYB)|Quarterly EPS earnings growth LEXX|PULM - Earnings per share growth in annualized terms for the last twelve months|Pheton Holdings - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Aptorum Group Ltd APM|LYRA: Year-over-year net earnings per share growth for the last 12 months|impactbiomedinc.com - Year-over-year earnings per share growth rate for the last twelve months|TNFA: Quarterly EPS earnings growth|YCBD - Year-over-year net earnings per share change for the last twelve months|PRFX (PainReform) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Auris Medical (CYTO)|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth OptiNose Corp (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals PIRS|procapsgroup.com - Year-over-year earnings per share growth for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Holding Group QLI|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months TFF Pharmaceuticals, Inc (TFFP)
